It has also been suggested that one explanation for the absence of a NAFLD phenotype might be upregulation of adiponectin, which activates the AMPK–forkhead box protein O (FOXO) signaling axis and probably overrides detrimental oxidative stress and JNK signaling [68] (Figure 1). This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.